AnalystsInsight

Matt Larew (William Blair): Analyst Track Record and Price‑Target Accuracy

Matt Larew is one of the top‑ranked analysts in Exent’s 7‑year backtest. What Matt covers, how Matt’s ratings lean, how fast price targets were reached and the ratings from before the last 30 days; the full record and the newest calls are members‑only.

Reviewed by:David, Senior AnalystPublished Oct 12, 2026Updated Oct 21, 20262 min readHow we research

Key takeaways

Matt Larew ranks among the top 50 healthcare analysts in Exent’s ranking, scored on a 7‑year backtest.
The exact rank, price‑target hit rate and live calls are members‑only in Exent Gems.
Matt published 4 ratings in the last 30 days, the latest on Oct 6, 2026.
Most‑covered stocks: ATR, WST, STVN, TMO.
In the past year Matt’s ratings were 73% Buy, 24% Hold and 3% Sell.

In this article

Matt Larew’s track record at a glance
How fast price targets were reached
Stocks Matt Larew covers most
Matt Larew’s latest ratings
How Exent scores analysts

Matt Larew’s track record at a glance

Matt Larew of William Blair ranks among the top 50 healthcare analysts in Exent’s ranking, with a focus on healthcare. The top of the ranking is what Exent Gems follows, so Matt’s exact rank, hit rate and live calls are for members.

Metric	Matt Larew	All analysts
Exent rank		—
Price‑target hit rate		53.6%
Calls up after 12 months		64.6%
Median 12‑month return of calls		+13.4%
Median days to hit target		91 days
Stocks covered	35	—

Unlock the full record in Gems

How fast price targets were reached

Time to reach the target	Matt Larew
Under 30 days	75.0%
30–90 days	0.0%
90–180 days	25.0%
Over 180 days	0.0%

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks Matt Larew covers most

ATR · WST · STVN · TMO · TWST · OPCH · TXG · TECH

In the past year Matt’s ratings were 73% Buy, 24% Hold and 3% Sell.

Matt Larew’s latest ratings

Date	Stock	Action	Rating	Price target
Oct 6, 2026
Oct 5, 2026
Sep 30, 2026
Sep 29, 2026
Sep 21, 2026	AVTR	Reiterated: Hold	Hold	$0.00
Sep 15, 2026	VCYT	Reiterated: Buy	Buy	$0.00
Sep 8, 2026	GH	Reiterated: Buy	Buy	$0.00
Sep 1, 2026	GH	Reiterated: Buy	Buy	$0.00
Aug 27, 2026	NEO	Rated: Hold	Hold	$0.00
Aug 25, 2026	GH	Reiterated: Buy	Buy	$0.00
Aug 24, 2026	QGEN	Rated: Hold	Hold	$0.00
Aug 20, 2026	SERA	Reiterated: Buy	Buy	$0.00
Aug 14, 2026	MDXH	Reiterated: Hold	Hold	$0.00
Aug 13, 2026	SERA	Reiterated: Buy	Buy	$0.00
Aug 12, 2026	TECH	Reiterated: Hold	Hold	$0.00
Aug 11, 2026	MASS	Reiterated: Buy	Buy	$0.00

Oct 6, 2026
Stock
Action
Rating
Price target
Oct 5, 2026
Stock
Action
Rating
Price target
Sep 30, 2026
Stock
Action
Rating
Price target
Sep 29, 2026
Stock
Action
Rating
Price target
Sep 21, 2026
Stock
AVTR
Action
Reiterated: Hold
Rating
Hold
Price target
$0.00
Sep 15, 2026
Stock
VCYT
Action
Reiterated: Buy
Rating
Buy
Price target
$0.00
Sep 8, 2026
Stock
GH
Action
Reiterated: Buy
Rating
Buy
Price target
$0.00
Sep 1, 2026
Stock
GH
Action
Reiterated: Buy
Rating
Buy
Price target
$0.00
Aug 27, 2026
Stock
NEO
Action
Rated: Hold
Rating
Hold
Price target
$0.00
Aug 25, 2026
Stock
GH
Action
Reiterated: Buy
Rating
Buy
Price target
$0.00
Aug 24, 2026
Stock
QGEN
Action
Rated: Hold
Rating
Hold
Price target
$0.00
Aug 20, 2026
Stock
SERA
Action
Reiterated: Buy
Rating
Buy
Price target
$0.00
Aug 14, 2026
Stock
MDXH
Action
Reiterated: Hold
Rating
Hold
Price target
$0.00
Aug 13, 2026
Stock
SERA
Action
Reiterated: Buy
Rating
Buy
Price target
$0.00
Aug 12, 2026
Stock
TECH
Action
Reiterated: Hold
Rating
Hold
Price target
$0.00
Aug 11, 2026
Stock
MASS
Action
Reiterated: Buy
Rating
Buy
Price target
$0.00

Matt published 4 ratings in the last 30 days, the latest on Oct 6, 2026. Ratings from the last 30 days are members‑only in Exent Gems, with the stocks where several top‑ranked analysts agree; older ratings are shown in full.

See the latest ratings in Gems

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Oct 20, 2026; ranking updated Oct 21, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

Exent Gems shows Matt Larew’s full record and latest ratings, without the 30‑day delay.
Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

See this week’s Gems

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring, Matt Larew ranks among the top 50 healthcare analysts in Exent’s ranking, based on a 7-year backtest of price-target hit rate, returns after calls and number of ratings. The exact rank, hit rate and live calls are members-only in Exent Gems (exent.ai/radar). Past accuracy does not guarantee future accuracy.

Matt Larew’s price-target hit rate is part of the members-only record in Exent Gems (exent.ai/radar). For comparison, the average analyst’s price targets were reached 53.6% of the time.

Matt Larew (William Blair) covers 35 stocks, mostly in healthcare. The most frequently rated are ATR, WST, STVN, TMO, TWST.

: .-++++=: .-=+**+-. .:=+*#*=:..::-+##*+-:. .-+**+++=:. .:::-=+**********++===++***+++*###*+=--:. .:==+*#*+-:..::-+##*+-:. :=**++=: .-=+**+-. .:=+*#*-...: . -++*+=: .:=+**+-. .:-+*#*=:..::=+##*=-:...:=***++=:. .:-=+*###*++==--:::::::...:---==+*##**++=-. .:-=+###*=-:...-+**++=: :=++*+-. :-=***=:..:-=*##+-..: :=+*++-. :=++*+=. :-=*#*+-..::=+##*=-:...-+*#*+=-. :-=+*###*+=--:. .... .::..:-=+++****=-:..::-=*#*+=-: .-=++++=. .-=+**+-...:=+##*=:.::-+##*=::. .-++++=: .-=+**=: .-=+*#+-...:-+##*=-::.:-+##*+=:. .-=++***+=-:::.. ..:-----:::::::. .:-=+*###*=-:.. :=+**++-. .-=+**+-. .:-+*##+:..:-=*##+-:..:=*#*+-:. :=+*++-. :=+**+-. .:=+*#*-...:-+*##+-:.::-+##*=-:. :=++**++-:...::::-==+++++****++===-:....:::-+*#*+==:. .-=+**+-. .:-=*##+-:.::-+##*=::.:-+##*=-:..-+#*+=:. .-++++=: .-++**=: :-=***=:..:-=*##+-:.::-+##*=-:...:=***++-: .:-==*###**+**####*******+=-::...:-+**++=-. :-=+##*-:..:-+###+-:..:=*#*+-:..:=*#*=-: :=**+=-. :=++++-. :=+**+-. .-=+**+-...-=+##*-:.::-+##*=-:...-+***+=-. .:-=+*####*+==========++*###*+=-:. .-=+***+-...:-=*##+-::.:-*##+=-:..-+#*+=-. .-+**+=: .-++++=: :=+*+=: .-=+**=: :-+***=: .:-+*#*=:..:-+###+-::.:-+##*=-:. .-=++****+---::. .::::--+****++=-. .:-+*##+-::.:-+##*=-:..:=*#*+-: .=**++-. :=+*++-. :=+**+: -++*+=. :=+**+-. .-=+**+-..:-=*##+-..:-=*##+-::.:-+##*=-:. :=+++*++-:...:.. ...:.. .:-=+**#*=:..::-+##*+-:...-+#*+=-. -+**+=: .-++*+=: .-++*+=. :=+**+- =+**+- .-=+**=: :-=*#*=:..:-+*#*=:.::-+##*=::.:-+##*=-:. .-+**++=-: .::---====---:. .::-=*##*=-:...-+##+=-: :=+*++-. .=++++-. :=+**+-. .-=+**+: .:-=*#*= =+**=: :-=***=. .:=+*#+-..:-=*##+-..:-=*##+-:.::=*##+-:...-+**++=:. .:-==+*###*+++++=-:..:::=*##*=-:. .-+**+=: -=+*+=: .-=+**=: :-=*#*=. .:=+*#+-..:-=*##+ =+**=. .:=+**+-. .-=*##+:..:-+*#*=:.::-+##*-::::=*##+=::..-+##*=-: :-=++*###**+++*###*=-::. .-+**+=-. :=++*+=. :-+**+-. .:=+*#+-..:-=*##+:..:-+##*=:.::=*##+ +**+-. .-=+**+:..:-+*#*=:..:=+##+-:.:-=*##+-:.:-+##*=-:..:+*#*=-:. .:=++***+=------=+*##*+=-. .-++*+=: .-=+**+: .-=*#*=:..:-+*#*=:.::=*##+-:.:-+##*=::.:-*##+ +**+-. :-=*#*=:..:-+##*-..:-=*##+-:.:-+##*=::.:-*##+-:..:=*#*+-:. .-+**++=-:. ..:...:-=+*++=-. :-+***=. .:-+*#*-...:=+##+-..:-=*#*=::::-+##+-::.:=*#*=-:..-+##+ +*#+:..:-+*#*=:..:=*##+-:.:-+##*=::::-*##+-:..:=*#*=-:..:+##+=-. .:+**++-: .::::. :-++**+:. .-=+##+:..:-=*#*=:..:-+##*-::::=*##+-:.:-+##*=::.:=*#*+-:..:+##+ *##+:..:-+##*-:.::=*##+-:::-+##*=::.:=*##+-:..-+##*=-...-*#*+-:. .=***+-: :-====-: .:-+*#*=:..:-+##*-:.::=*##+-:.:-+##*=::.:=*##+-:..:+##+=-...-*#*+-:. :+**+ *##=:..:-+##*-:.::=*##=-:.:-+##+-:..:=*#*=-:..-+##+=:. :=*#*=-: :+**+=:. .-=++**#*+-..:-=*##+-:.:-+##*=::.:=*##+-:..:+##*=-:..-*#*+-:..:+**+=-. .-***+-: :=**+ *##=::::-+##+-::::=##*=-:.:-*##+-:..:=##*=-:..-+#*+-:. :=**+=-. .-+**+=: :=+*+++##*=::::=*##+-:.::+##*=-:.:-*##+-:..:+##*=-...-*#*+-: :=**+=-. .-+*++-. :=+*+ ##*=::.:-*##+-:..:=##*=-:..-*#*+-:..:=*#+=-. .-+**+-: :=**+=-. .-+*++=. :=++++*##*=::.:=*##+-:..:+##*=-:..-*#*+-:..:+**+=-. .-***+-: :=**+=: .-+*++-. :=+++ ##*=-:..-*##+-:..:=*#*=-...-+#*+-:. :=**+=-. .-+**+=: .=+*+=-. -=+*+=: .-=+*###*=-:..:=*#*=-:..-+##+=:...=*#*=-: :+**+=:. .-+*++-. :=**+=: .-++++-. :=+** ##*=-:..-+#*+-:. :=**+=-. .-+**+=: .=**+=-. :++++=: .-++*+-. :=+**+-. .:--=++=-:::.:-*##+=:...-*#*+-:. :=**+=-. -+**+=: .=+*+=-. :=+++=: .-++*+-. .-=+** *#*=-: .-+**+=:. .=**+=-. :+**+=: .-++++-. :=+**+: .-=+**=: :-=+##+-:...........::-+##*=-:..:=*#*=-. :+**+=:. .-+*++-. :=+*+=- .-++*+=. :=+**+- .-=+** ***=-. :+**+=: .-+*++-. :=+++=: .-=+*+=. :-+**+-. .:=+*#*-:..:-+*##*=--:. .:--=*##*=-:...-*#*+=:. .-+**+-: .=+*+=-. :=+*+=: .-++*+-. :=+**+: :-=*** +*++-. :=+*+=: .-++*+=. :=+**+-. .:=+**+: :-=*#*+:..:-=*##+-::.:-=*##*+==------==+*##*=-:...-+##+=-. :+**+=-. :++*+=: .-++*+=. :=+**+-. .-=+**=: .:-+*#* ++++=: :=++*+-. .:=+**=: .-=***=. .:-+*#*-...:=+##*=::::-+##*+-:.. .-++++**##***++**#*+-::..:-+##*=-:. .=***+=: .-+*++-. :=++*+-. .-=+**+: :-=*#*=. .:=+##+ =+*+=: .-++**=. .:=+**+-. .-=+##+-..:-=*##+-:.:-=*##+-:...-+##*+=:. .:-==+*###**++++=-:..:::=*##*=-:. .-+**+=:. :=+*+=: .-=+**=: .-=***=. .:=+*#+-..:-=*##+ =+**+-. .-=+**=:..:-+*#*=:..:-+##*=:.::-+##*=::..-+##*=-:. .-++*+++-: .::::--====--:. .::-+*##*=-:. .-+**+=-. :=+*++-. :=++*+-. .:=+**+-. .-=+##+:..:-+*#*= -+*#*=...:=+##+-..:-=*##+-:.:-=###+-:..:=*#*+-:. .-+**+=-. .:=++*#*+-:::.. .::.. .:--=+###*=-:...-+**+=-: .-+*++=: .-=+**=: .-=+**=: .:-+*#*=:..:=+##*- -=*##=:..:-+##*=::::-+##*=::..-*##+=-. .-+**+=-. .-++**+-. .:-=*###*+=--:.....:::..:--=++*##*+-::..:-+##*=-: .-+**+=-. :=+**+-. .:=+*#+-...-=+##+-..:-=*##+- :=*##+-::::=*##+-:..:=*#*=-:. :=***+-: .-++++=-. :-=+*#*=:..:::-=****++*+++======++********=-:..::-=*##*=-:. .-+**++-. .-++**=: :-=***=:..:-=*#*=:..:-+##*=: :-+##*=-:..-+##+=-. .-+**+=:. :++*++-. :-++**+-. .:-=*##*+--:. .:==++*####**++*####**++==:. .:--+###*=-:. .-+**++-: .-=+**+: .-=+*#+-...-=+##+-..:-=*##+-: .:=*#*=-:. :=**+=-: :=+*++-. .-=+**+:. .:-+*##+-:::::=+##*+=-:. .:--==+**++++****+==--: :--=*###+=-:...-+**++-: .-=+**+-. :-+***=:..:-+*#*=:..:-+##*=:: .-+**+=:. .-+**+=: .-=+**+-. .:-+*#*+:..::-+###+=-:. .:=+***++=-:........::-----::::::.. :-==+*##*=-::..:=*#*+=-: .:=++++-. :-=+**+:..:-=*##+-..:-=*##+-:: :=+*++-. :=++*+=. :-=***+-..::=+##*=-::.:-+*#*+=-: :-=+*###*+=--:. ..:. .:::::-=+++****=-:..::-=*##+=-:. .-=+*++=: .-=+**+-. .:=+##*=:.::-+##*=::. .-=+**=: .-=+**+-...:-+##*=-::::=*##*=-:. .:=+*+++=:. .::-=+*##**++==--::::::...::---=+**#**+++=:. ..:-=+###+=-:. .-+**++=: .-=+**+-. .:-+*#*=:..:-=*##+-::: . :-+***=:..:-=*##+-:.::=*##*=-:..:-+**+=-: :-=+*#*+=:::...:-=++++*###**++=+++++++++**###*+==-:. .:-=+*##*+-::...-+**++-: .:=+**+=. :-=*##+-..::=*##*-::.:

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Insight

Are Analyst Price Targets Accurate? 7 Years of Data

How often Wall Street price targets are reached, how long it takes, and how the promised upside compares with what stocks actually did. From Exent’s backtest of 628,792 analyst ratings.

Oct 16, 2026 · 7 min read

Guide

How to Follow Wall Street Analysts the Smart Way: Track Records, Not Headlines

“Analyst upgrades stock” tells you almost nothing. Who made the call, and how often they have been right, tells you a lot. Here is how to follow the analysts worth following, and what the evidence says about doing it.

Oct 12, 2026 · 7 min read

Guide

What Are Exent Gems? Top‑Analyst Agreement Explained

Gems are stocks where several of Wall Street’s best-rated analysts agree. Here is what analyst convergence means, how a stock becomes a Gem, what the data behind it shows, and where its limits are.

Oct 12, 2026 · 6 min read

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.